Vimarsana
Biggest News Aggregation in the World

Veronica Eames News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Veronica Eames. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Veronica Eames Today - Breaking & Trending Today

Cidara Therapeutics Announces Reverse Stock Split - Vimarsana News

Cidara Therapeutics Announces Reverse Stock Split

SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...

Cidara Therapeutics Provides Corporate Update and Reports - Vimarsana News

Cidara Therapeutics Provides Corporate Update and Reports

SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...

Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice - Vimarsana News

Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice

22.04.2024 - SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) - Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and ...

Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024 - Vimarsana News

Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024

AU ZH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- Araris Biotech AG ("Araris" or "the Company"), a company pioneering a proprietary antibody-drug conjugate (ADC)- technology, today announced the company will